Journal Article DKFZ-2026-00461

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Increase in second primary lung cancers in a nation-wide cohort study from Sweden.

 ;  ;  ;  ;  ;  ;

2026
BMJ Publishing Group London

Thorax nn, nn () [10.1136/thorax-2025-223426]
 GO

Abstract: We describe the occurrence of second primary lung cancers (SPLCs) and their determinant in Sweden.Nation-wide cancer registry from years 1961 to 2021 identified a total of 853 SPLCs.The incidence of SPLCs increased almost linearly from 1980 onwards, equally for women and men and approximately equally after the four main histological types. SPLC included adenocarcinoma 63.9%, squamous cell carcinoma (SCC) 19.4%, small cell carcinoma 9.6% and large cell carcinoma 9.1%. The female cumulative probability (CumP) of SPLC after first adenocarcinoma in 10 years reached 0.019, after SCC 0.015 and after small and large cell carcinoma 0.008. The respective CumP for men was 0.013, 0.012, 0.002 and 0.005. While adenocarcinoma was often followed by second adenocarcinoma, after first non-adenocarcinoma SPLCs presented in diverse histologies. Relative risk of SPLC compared with first lung cancer was overall 3.59, higher for women (4.16) than for men (2.99) and approximately equally high after adenocarcinoma and SCC. In patients diagnosed before age 55 years, the relative risk was 6.68 for all, but after female adenocarcinoma it was 9.95 compared with 6.77 for males. The highest relative risks, up to 20-fold, were found after early onset female adenocarcinoma diagnosed after defined T stages.Although SPLCs are still rare, their number is increasing rapidly and the relative risks compared with first lung cancer are substantial, qualifying selected groups of high-risk patients, such as patients with early onset adenocarcinoma for early detection by CT screening when/if such tests become available.

Keyword(s): Histology/Cytology ; Lung Cancer ; Rare lung diseases

Classification:

Note: #LA:Z999# / epub

Contributing Institute(s):
  1. B062 Pädiatrische Neuroonkologie (B062)
  2. Epidemiologie von Krebs (C020)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; National-Konsortium ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > C020
Public records
Publications database

 Record created 2026-02-27, last modified 2026-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)